Literature DB >> 4352576

Measurement of inorganic pyrophosphate in biological fluids. Elevated levels in some patients with osteoarthritis, pseudogout, acromegaly, and uremia.

D C Silcox, D J McCarty.   

Abstract

A rapid and relatively simple method for measurement of inorganic pyrophosphate (PPi) in biological samples has been described. The mean +/-SEM of plasma samples from 94 normal subjects was 1.8+/-0.06 muM, giving a normal range (99% confidence limits) of 0.16 - 3.40 mumol/liter. Analysis of 17 plasma samples in duplicate showed a standard deviation of 0.18, giving a 99% probability that a single determination of plasma PPi would be +/-0.68 muM of the true value. The mean PPi levels in plasma from subjects with osteoarthritis, pseudogout, acromegaly, and uremia were significantly greater than the normal mean (P < 0.01). Samples from rheumatoid arthritis showed PPi levels distributed about a mean identical to the normal mean. Plasma inorganic orthophosphate levels correlated positively with PPi levels in samples from normal subjects and in samples from patients with osteoarthritis, pseudogout, and uremia, but not with acromegaly. This correlation was statistically significant only in the normal samples and in those from patients with osteoarthritis.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4352576      PMCID: PMC302467          DOI: 10.1172/JCI107369

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  17 in total

1.  Hydrolysis of nucleoside diand triphosphates by crystalline preparations of yeast inorganic pyrophosphatase.

Authors:  M J SCHLESINGER; M J COON
Journal:  Biochim Biophys Acta       Date:  1960-06-17

2.  A colorimetric determination of inorganic pyrophosphate.

Authors:  R M FLYNN; M E JONES; F LIPMANN
Journal:  J Biol Chem       Date:  1954-12       Impact factor: 5.157

3.  Inorganic pyrophosphate concentrations in the synovial fluid of arthritic patients.

Authors:  D J McCarty; S D Solomon; M L Warnock; E Paloyan
Journal:  J Lab Clin Med       Date:  1971-08

4.  Micro procedure for determination of pyrophosphate and orthophosphate.

Authors:  G B Grindey; C A Nichol
Journal:  Anal Biochem       Date:  1970-01       Impact factor: 3.365

5.  An enzymic method for determination of inorganic pyrophosphate and its use as an assay for RNA polymerase.

Authors:  J C Johnson; M Shanoff; S T Bass; J A Boezi; R G Hansen
Journal:  Anal Biochem       Date:  1968-10-10       Impact factor: 3.365

6.  Isotope derivative method for determination of microquantities of inorganic pyrophosphate in biological material.

Authors:  H Flodgaard
Journal:  Eur J Biochem       Date:  1970-08

7.  [Calcic microscystalline arthritis (pseudo-gout) in a patient with acromegaly].

Authors:  M Lamotte; J M Segrestaa; G Krassinine
Journal:  Sem Hop       Date:  1966-10-08

8.  Inorganic pyrophosphate in plasma, urine, and synovial fluid of patients with pyrophosphate arthropathy (chondrocalcinosis or pseudogout).

Authors:  R G Russell; S Bisaz; H Fleisch; H L Currey; H M Rubinstein; A A Dietz; I Boussina; A Micheli; G Fallet
Journal:  Lancet       Date:  1970-10-31       Impact factor: 79.321

9.  Erythrocyte neutral inorganic pyrophosphatase in pseudogout.

Authors:  D J McCarty; P F Pepe
Journal:  J Lab Clin Med       Date:  1972-02

10.  Inorganic pyrophosphate in plasma in normal persons and in patients with hypophosphatasia, osteogenesis imperfecta, and other disorders of bone.

Authors:  R G Russell; S Bisaz; A Donath; D B Morgan; H Fleisch
Journal:  J Clin Invest       Date:  1971-05       Impact factor: 14.808

View more
  9 in total

1.  Crystals and arthritis.

Authors: 
Journal:  Br Med J       Date:  1979-03-10

2.  Inorganic pyrophosphate pool size and turnover rate in arthritic joints.

Authors:  M Camerlain; D J McCarty; D C Silcox; A Jung
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

3.  Familial chondrocalcinosis in the Chiloe Islands, Chile.

Authors:  A J Reginato; J L Hollander; V Martinez; F Valenzuela; V Schiapachasse; E Covarrubias; S Jacobelli; R Arinoviche; D Silcox; F Ruiz
Journal:  Ann Rheum Dis       Date:  1975-06       Impact factor: 19.103

4.  Plasma pyrophosphate and vascular calcification in chronic kidney disease.

Authors:  W Charles O'Neill; Mhairi K Sigrist; Christopher W McIntyre
Journal:  Nephrol Dial Transplant       Date:  2009-07-24       Impact factor: 5.992

5.  Synovial fluid pyrophosphate and nucleoside triphosphate pyrophosphatase: comparison between normal and diseased and between inflamed and non-inflamed joints.

Authors:  M Pattrick; E Hamilton; J Hornby; M Doherty
Journal:  Ann Rheum Dis       Date:  1991-04       Impact factor: 19.103

6.  Tumoral calcinosis: evidence for concurrent defects in renal tubular phosphorus transport and in 1 alpha,25-dihydroxycholecalciferol synthesis.

Authors:  J E Zerwekh; L A Sanders; J Townsend; C Y Pak
Journal:  Calcif Tissue Int       Date:  1980       Impact factor: 4.333

7.  A Reference Range for Plasma Levels of Inorganic Pyrophosphate in Children Using the ATP Sulfurylase Method.

Authors:  Eva Bernhard; Yvonne Nitschke; Gus Khursigara; Yves Sabbagh; Yongbao Wang; Frank Rutsch
Journal:  J Clin Endocrinol Metab       Date:  2022-01-01       Impact factor: 5.958

Review 8.  Hypophosphatasia.

Authors:  Symeon Tournis; Maria P Yavropoulou; Stergios A Polyzos; Artemis Doulgeraki
Journal:  J Clin Med       Date:  2021-12-01       Impact factor: 4.241

9.  Alkalosis and Dialytic Clearance of Phosphate Increases Phosphatase Activity: A Hidden Consequence of Hemodialysis.

Authors:  Ricardo Villa-Bellosta; Emilio González-Parra; Jesús Egido
Journal:  PLoS One       Date:  2016-07-25       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.